Chemir Analytical Services (Maryland Heights, MO) acquired Gateway Chemical Technology, Inc., (St. Louis, MO), a provider of custom synthesis and process development services.
Chemir Analytical Services (Maryland Heights, MO, www.chemir.com)acquired Gateway Chemical Technology, Inc., (St. Louis, MO, www.gatewaychemical.com),a provider of custom synthesis and process development services.
"The purchase of Gateway Chemical Technology is a key step in our nextlevel of growth" said Shri Thanedar, PhD, CEO of Chemir, in a companyrelease. "In fact, we plan to expand soon to a new building. This willbe a dedicated CGMP/FDA regulated laboratory, perfect for our growingstaff of pharmaceutical chemists."
Chemir will expand its Maryland Heights facility from 25,000 to 50,000ft2, with a staff projected at 100 by 2008.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.